Marc N. Casper - Dec 2, 2024 Form 4 Insider Report for THERMO FISHER SCIENTIFIC INC. (TMO)

Signature
/s/ Melodie T. Morin, Attorney-in-Fact for Marc N. Casper
Stock symbol
TMO
Transactions as of
Dec 2, 2024
Transactions value $
-$10,624,559
Form type
4
Date filed
12/4/2024, 04:13 PM
Previous filing
Nov 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMO Common Stock Sale -$264K -500 -0.41% $528.02 121K Dec 2, 2024 Direct F1, F2
transaction TMO Common Stock Sale -$1.28M -2.42K -2.01% $529.32 118K Dec 2, 2024 Direct F1, F3
transaction TMO Common Stock Sale -$2.61M -4.92K -4.16% $530.05 113K Dec 2, 2024 Direct F1, F4
transaction TMO Common Stock Sale -$403K -759 -0.67% $530.91 113K Dec 2, 2024 Direct F1, F5
transaction TMO Common Stock Sale -$213K -400 -0.36% $531.77 112K Dec 2, 2024 Direct F1, F6
transaction TMO Common Stock Sale -$320K -600 -0.53% $533.17 112K Dec 2, 2024 Direct F1, F7
transaction TMO Common Stock Sale -$214K -400 -0.36% $534.24 111K Dec 2, 2024 Direct F1, F8
transaction TMO Common Stock Sale -$211K -400 -0.36% $528.67 111K Dec 3, 2024 Direct F1, F9
transaction TMO Common Stock Sale -$212K -400 -0.36% $529.53 110K Dec 3, 2024 Direct F1, F10
transaction TMO Common Stock Sale -$714K -1.35K -1.22% $530.88 109K Dec 3, 2024 Direct F1, F11
transaction TMO Common Stock Sale -$1.78M -3.35K -3.07% $532.04 106K Dec 3, 2024 Direct F1, F12
transaction TMO Common Stock Sale -$1.84M -3.45K -3.26% $533.04 102K Dec 3, 2024 Direct F1, F13
transaction TMO Common Stock Sale -$561K -1.05K -1.03% $533.95 101K Dec 3, 2024 Direct F1, F14
transaction TMO Common Stock Sale -$2.67K -5 0% $534.71 101K Dec 3, 2024 Direct F1
holding TMO Common Stock 11.3K Dec 2, 2024 By Alison Casper 2020 Irrevocable Trust F15
holding TMO Common Stock 14.6K Dec 2, 2024 By Floral Park Associates, Inc.
holding TMO Common Stock 5K Dec 2, 2024 By MNC 2020 Irrevocable Trust F16
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 7, 2024.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $527.52 to $528.50, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13) and (14) to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $528.66 to $529.65, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $529.66 to $530.57, inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $530.58 to $531.09, inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $531.64 to $531.90, inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $532.71 to $533.45, inclusive.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $534.05 to $534.43, inclusive.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $528.24 to $529.09, inclusive.
F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $529.33 to $529.72, inclusive.
F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $530.34 to $531.24, inclusive.
F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $531.52 to $532.51, inclusive.
F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $532.53 to $533.50, inclusive.
F14 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $533.57 to $534.56, inclusive.
F15 The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.
F16 The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.